# CBX5

## Overview
CBX5 is a gene that encodes the protein heterochromatin protein 1 alpha (HP1α), a member of the heterochromatin protein 1 (HP1) family, which plays a pivotal role in chromatin organization and gene regulation. HP1α is a chromatin-associated protein characterized by its chromodomain and chromoshadow domain, which facilitate interactions with methylated histones and other nuclear proteins, respectively (Lomberk2006Theheterochromatinprotein1family; Kaustov2011Recognition). The protein is primarily involved in the formation and maintenance of heterochromatin, contributing to transcriptional repression and genome stability (van2021Biological). CBX5's function is critical for various cellular processes, including DNA repair, replication, and transcriptional regulation, and its dysregulation has been implicated in diseases such as acute myeloid leukemia (Prieto2021Transcriptional).

## Structure
The CBX5 gene encodes the HP1α protein, which is a member of the heterochromatin protein 1 (HP1) family. HP1α is characterized by two main domains: the chromodomain and the chromoshadow domain. The chromodomain, located in the amino-terminal half of the protein, is approximately 30-60 amino acids long and is involved in binding methylated lysine 9 of histone H3, leading to transcriptional repression (Lomberk2006Theheterochromatinprotein1family). This domain has a globular conformation with an antiparallel three-stranded β sheet and an α helix, forming a hydrophobic groove for protein interaction (Lomberk2006Theheterochromatinprotein1family). The chromoshadow domain, found in the carboxy-terminal half, enables dimerization and serves as a docking site for various nuclear proteins (Lomberk2006Theheterochromatinprotein1family).

The chromodomain of CBX5 forms an aromatic cage that interacts with trimethylated lysine residues on histones, crucial for its role in chromatin organization (Kaustov2011Recognition). The electrostatic surface charge distribution of CBX5 influences its binding affinity to histone peptides (Kaustov2011Recognition). Post-translational modifications, such as phosphorylation, affect HP1α's localization and function (Lomberk2006Theheterochromatinprotein1family). The protein's structure and interactions are essential for its role in chromatin dynamics and gene regulation (Dahiya2019Investigating).

## Function
CBX5, also known as heterochromatin protein 1 alpha (HP1α), is a crucial component in maintaining chromatin structure and gene repression in healthy human cells. It is part of the heterochromatin protein 1 (HP1) family and plays a significant role in chromatin compaction by binding to methylated histone H3 at lysine 9 (H3K9me3) marks, which are associated with gene silencing (van2021Biological). CBX5 is involved in the formation and maintenance of heterochromatin, contributing to genome stability and proper chromosome segregation during cell division (van2021Biological).

CBX5 also interacts with the H3K9 methyltransferase SUV39H1, which helps spread the repressive H3K9me3 marks, further promoting gene silencing (van2021Biological). This protein is essential for maintaining the nuclear organization and chromosomal stability, as its loss can lead to chromatin defects and alterations in nuclear organization (van2021Biological). CBX5 is active primarily in the nucleus, where it supports various cellular processes, including DNA repair, replication, and transcriptional regulation (van2021Biological). These functions are vital for maintaining cellular identity and ensuring proper cell differentiation and development (van2021Biological).

## Clinical Significance
Alterations in the expression of the CBX5 gene, which encodes heterochromatin protein 1 alpha (HP1α), have significant clinical implications, particularly in the context of myeloid leukemia. In acute myeloid leukemia (AML), CBX5 is highly expressed in leukemia stem cell populations, and its depletion has been shown to reduce leukemia cell colony formation, indicating its role in leukemia cell survival and proliferation (Prieto2021Transcriptional). The regulation of CBX5 by RNA-binding proteins RBMX and RBMXL1 is crucial for maintaining chromatin organization and integrity, which is essential for the survival of leukemia cells. Disruption of this regulatory pathway is associated with worse outcomes in AML patients (Prieto2021Transcriptional).

The study by Prieto et al. highlights that RBMX and RBMXL1 directly control the transcription of CBX5, and their depletion leads to reduced CBX5 transcription, resulting in decreased cell proliferation and increased apoptosis in leukemia cells (Prieto2021Transcriptional). This suggests that CBX5 plays a critical role in maintaining the chromatin state necessary for leukemia cell survival. The overexpression of CBX5 can rescue certain cellular defects caused by the loss of RBMX/RBMXL1, further underscoring its importance in leukemogenesis (Prieto2021Transcriptional).

## Interactions
CBX5, also known as chromobox 5, encodes the heterochromatin protein 1 alpha (HP1α), which is involved in various interactions with chromatin components and other proteins. HP1α interacts with histone H3 when it is trimethylated at lysine 9 (H3K9me3), a key marker for heterochromatin, facilitating chromatin compaction and gene silencing (Kumar2020Heterochromatin; Kaustov2011Recognition). This interaction is mediated by the chromodomain of HP1α, which recognizes the methylated lysine and binds within an aromatic cage formed by specific residues (Kaustov2011Recognition).

HP1α also interacts with the histone variants H2A and H2A.Z, with H2A.Z enhancing HP1α binding to chromatin, mimicking the effect of H3K9me3 (Kumar2020Heterochromatin). Additionally, HP1α interacts with the linker histone H1, particularly with the H1b variant and methylated H1.4, although phosphorylation can disrupt this binding, leading to chromatin relaxation (Kumar2020Heterochromatin).

In the context of myeloid leukemia, CBX5 expression is regulated by RNA-binding proteins RBMX and RBMXL1, which bind to CBX5 transcripts and influence its mRNA and protein levels, affecting chromatin organization and integrity (Prieto2021Transcriptional). These interactions highlight the role of CBX5 in maintaining chromatin state and its potential implications in leukemia progression (Prieto2021Transcriptional).


## References


[1. (Kaustov2011Recognition) Lilia Kaustov, Hui Ouyang, Maria Amaya, Alexander Lemak, Nataliya Nady, Shili Duan, Gregory A. Wasney, Zhihong Li, Masoud Vedadi, Matthieu Schapira, Jinrong Min, and Cheryl H. Arrowsmith. Recognition and specificity determinants of the human cbx chromodomains. Journal of Biological Chemistry, 286(1):521–529, January 2011. URL: http://dx.doi.org/10.1074/jbc.M110.191411, doi:10.1074/jbc.m110.191411. This article has 355 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M110.191411)

[2. (van2021Biological) Andre J. van Wijnen, Leila Bagheri, Amr A. Badreldin, A. Noelle Larson, Amel Dudakovic, Roman Thaler, Christopher R. Paradise, and Zhong Wu. Biological functions of chromobox (cbx) proteins in stem cell self-renewal, lineage-commitment, cancer and development. Bone, 143:115659, February 2021. URL: http://dx.doi.org/10.1016/j.bone.2020.115659, doi:10.1016/j.bone.2020.115659. This article has 59 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.bone.2020.115659)

[3. (Prieto2021Transcriptional) Camila Prieto, Diu T. T. Nguyen, Zhaoqi Liu, Justin Wheat, Alexendar Perez, Saroj Gourkanti, Timothy Chou, Ersilia Barin, Anthony Velleca, Thomas Rohwetter, Arthur Chow, James Taggart, Angela M. Savino, Katerina Hoskova, Meera Dhodapkar, Alexandra Schurer, Trevor S. Barlowe, Ly P. Vu, Christina Leslie, Ulrich Steidl, Raul Rabadan, and Michael G. Kharas. Transcriptional control of cbx5 by the rna-binding proteins rbmx and rbmxl1 maintains chromatin state in myeloid leukemia. Nature Cancer, 2(7):741–757, July 2021. URL: http://dx.doi.org/10.1038/s43018-021-00220-w, doi:10.1038/s43018-021-00220-w. This article has 12 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s43018-021-00220-w)

[4. (Kumar2020Heterochromatin) Amarjeet Kumar and Hidetoshi Kono. Heterochromatin protein 1 (hp1): interactions with itself and chromatin components. Biophysical Reviews, 12(2):387–400, March 2020. URL: http://dx.doi.org/10.1007/s12551-020-00663-y, doi:10.1007/s12551-020-00663-y. This article has 52 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12551-020-00663-y)

[5. (Dahiya2019Investigating) Rashmi Dahiya, Ahmad Abu Turab Naqvi, Taj Mohammad, Mohamed F. Alajmi, Md. Tabish Rehman, Afzal Hussain, and Md. Imtaiyaz Hassan. Investigating the structural features of chromodomain proteins in the human genome and predictive impacts of their mutations in cancers. International Journal of Biological Macromolecules, 131:1101–1116, June 2019. URL: http://dx.doi.org/10.1016/j.ijbiomac.2019.03.162, doi:10.1016/j.ijbiomac.2019.03.162. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ijbiomac.2019.03.162)

[6. (Lomberk2006Theheterochromatinprotein1family) Gwen Lomberk, Lori Wallrath, and Raul Urrutia. The heterochromatin protein 1 family. Genome Biology, 7(7):228, 2006. URL: http://dx.doi.org/10.1186/gb-2006-7-7-228, doi:10.1186/gb-2006-7-7-228. This article has 337 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/gb-2006-7-7-228)